Stock Price
1,420.00
Daily Change
-6.20 -0.43%
Monthly
15.49%
Yearly
-2.37%
Q2 Forecast
1,401.45

Cipla reported INR3.82B in Loan Capital for its fiscal quarter ending in March of 2026.





Loan Capital Change Date
aTyr Pharma USD 12.51M 12.11M Dec/2025
Bio Path USD 0 0 Mar/2025
Brainstorm Cell Therapeutics USD 0 0 Mar/2025
Capricor Therapeutics USD 3.38M 0 Mar/2025
Cara Therapeutics USD 0 0 Mar/2025
Cipla INR 3.82B 840.2M Mar/2026
Dr.Reddys Laboratories INR 12.2B 595M Mar/2026
Esperion Therapeutics USD 457.65M 9.5M Dec/2025
Immunic USD 0 0 Jun/2024
Infinity Pharmaceuticals USD 0 0 Jun/2022
Minerva Neurosciences USD 0 86.58M Sep/2024
Nektar Therapeutics USD 63.16M 44.35M Dec/2025
Sangamo BioSciences USD 0 0 Jun/2022
Sun Pharmaceuticals INR 3.62B 36.4M Sep/2025
TherapeuticsMD USD 0 0 Mar/2022
UPL INR 165.56B 16.81B Mar/2026